Financial and Inpatient Burden of Adhesion-Related Small Bowel Obstruction: A Systematic Review of the Literature

Abstract

Background Postoperative adhesions may occur after >90% of laparotomies and is the most common cause of small bowel obstruction (SBO). Despite the high incidence, there is a lack of data related to financial implications of adhesion-related SBO (ASBO). This systematic literature review of in-hospital costs for treatment of ASBO searched PubMed, Scopus and Google Scholar databases according to PRISMA guidelines. Exclusion criteria were reviews, editorials, clinical vignettes, studies of patients <18 years of age, studies with no English full text and studies assessing adhesiolysis for causes other than SBO or that used extrapolations with economic models. Main outcome measures were financial costs per patient and national costs. Results Seven studies, published between 1999 and 2016, incorporating a total of 39 573 patients, were identified. Four were undertaken in European countries, one in the USA, 1 in New Zealand and 1 in Nigeria. Overall national costs regarding treatment of patients with ASBO ranged between $3.468 million and $1.77 billion. Median overall cost in the medical management group was $2371.5 ($1814-$2568) vs $12370 ($4914-$25321) in the surgical group. Median length of stay was 4 (3-7) days for patients conservatively treated and 11.5 (8-16.3) days for patients who underwent surgery. Median length of stay of operated patients on was almost triple that of patients conservatively managed. Conclusions Given the major financial implications of ASBO, further initiatives are needed to avoid operations for SBO when clinically appropriate and minimize delays taking patients with high suspicion of complete SBO to the operating room.

Contemporary Assessment of Adhesiolysis and Resection for Adhesive Small Bowel Obstruction in the State of New York

“…In the United States, adhesive small bowel obstruction (aSBO) is an extremely common cause of hospital admission and operation. 1,2 The fundamental surgical treatment for aSBO, peritoneal adhesiolysis, has not changed significantly since the first adhesiolysis was described in London in 1882. 3 Successful management of aSBO requires a strategy that optimizes the timing of surgical intervention, when necessary, and minimizes the risk of future recurrence.…”

“…In the United States, adhesive small bowel obstruction (aSBO) is an extremely common cause of hospital admission and operation. 1,2 The fundamental surgical treatment for aSBO, peritoneal adhesiolysis, has not changed significantly since the first adhesiolysis was described in London in 1882. 3…”